60 results on '"Di Nisio, Marcello"'
Search Results
2. Direct oral anticoagulants: The new standard of care for cancer associated thrombosis
3. Age- versus clinical pretest probability-adjusted D-dimer to rule out lower-extremity deep vein thrombosis in ambulatory patients with active cancer
4. Inflammasome Signaling, Thromboinflammation, and Venous Thromboembolism
5. Clinical course and treatment of incidentally detected splanchnic vein thrombosis: an individual patient data meta-analysis
6. Anamnestic frailty phenotype and adverse outcomes in patients treated with direct oral anticoagulants: Validation and comparative performance with frailty phenotype
7. Apixaban thromboprophylaxis in ambulatory patients with cancer and obesity: Insights from the AVERT trial
8. Antithrombotic treatment for retinal vein occlusion: a systematic review and meta-analysis
9. Platelet RNA sequencing for cancer screening in patients with unprovoked venous thromboembolism: a prospective cohort study
10. Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis Day
11. Venous thromboembolism in pancreatic cancer patients: Time to consider routine thromboprophylaxis?
12. Targeting the NLRP3 inflammasome in cardiovascular diseases
13. Anticoagulant treatment for upper extremity deep vein thrombosis: A systematic review and meta‐analysis
14. Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban
15. The prognostic value of respiratory symptoms and performance status in ambulatory cancer patients and unsuspected pulmonary embolism; analysis of an international, prospective, observational cohort study
16. Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation
17. Extended venous thromboprophylaxis in patients hospitalized for acute ischemic stroke: A systematic review and meta-analysis
18. Effect of dexamethasone on direct Xa-inhibitor oral anticoagulant plasma levels in patients with COVID-19
19. Treatment of venous thromboembolism in cancer patients: The dark side of the moon
20. Clinical history of cancer‐associated splanchnic vein thrombosis
21. Novel biomarkers to detect occult cancer in patients with unprovoked venous thromboembolism: Rationale and design of the PLATO-VTE study
22. Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19
23. Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis
24. Low-dose subcutaneous tocilizumab to prevent disease progression in patients with moderate COVID-19 pneumonia and hyperinflammation
25. Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis
26. Underlying disorders of disseminated intravascular coagulation: Communication from the ISTH SSC Subcommittees on Disseminated Intravascular Coagulation and Perioperative and Critical Care Thrombosis and Hemostasis
27. The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta‐analysis
28. Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta‐analysis
29. Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis‐associated coagulopathy: A systematic review and meta‐analysis
30. Anticoagulant therapy for splanchnic vein thrombosis
31. Prediction of venous thromboembolism in patients with lower-limb immobilization
32. Management of venous thromboembolism in cancer patients: Considerations about the clinical practice guideline update of the American society of clinical oncology
33. Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post‐hoc analysis of the Hokusai‐VTE Cancer study
34. The Ottawa score performs poorly in cancer patients with incidental pulmonary embolism
35. Bleeding and venous thromboembolic events in patients with active cancer hospitalized for an acute medical illness
36. Effects of multiple inherited and acquired thrombophilia on outcomes of in-vitro fertilization
37. A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts
38. Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study
39. The diagnostic management of upper extremity deep vein thrombosis: A review of the literature
40. Recanalization rate in patients with proximal vein thrombosis treated with the direct oral anticoagulants
41. Diagnosis of overt and non-overt disseminated intravascular coagulation: A survey among experts and a call for action from the ISTH
42. A clinical decision rule and D-dimer testing to rule out upper extremity deep vein thrombosis in high-risk patients
43. Deep vein thrombosis and pulmonary embolism
44. Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation
45. Clinical course of upper extremity deep vein thrombosis in patients with or without cancer: a systematic review
46. Rivaroxaban for Cancer-associated Cardiac Thrombosis
47. Management of disseminated intravascular coagulation: A survey of the International Society on Thrombosis and Haemostasis
48. Cancer-associated unsuspected pulmonary embolism
49. Heart Failure and Cognitive Impairment: Relationships with Mortality
50. C0208 Prevention of venous thromboembolism in acutely ill medical patients with renal impairment: The fondair study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.